National Institute of Diabetes and Digestive and Kidney Disorders; Notice of Closed Meeting, 28831 [E8-10950]

Download as PDF Federal Register / Vol. 73, No. 97 / Monday, May 19, 2008 / Notices Date: June 18, 2008. Time: 1 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Serena P. Chu, PhD, Scientific Review Administrator, Division of Extramural Activities, National Institute of Mental Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 6154, MSC 9609, Rockville, MD 20892, 301–443–0004, sechu@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: May 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–11085 Filed 5–16–08; 8:45 am] BILLING CODE 4140–01–M Name of Committee: Type I Diabetes— Rapid Access to Intervention Development, Special Emphasis Panel, National Institute of Diabetes and Digestive and Kidney Diseases. Date: June 3, 2008. Time: 12 p.m.–1 p.m. Agenda: To evaluate requests for preclinical development resources for potential new therapeutics for type I diabetes and its complications. Place: 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Dr. Kristin Abraham, Director, Cell Signaling and Diabetes Centers Program, Division of Diabetes, Endocrinology and Metabolic Diseases, NIDDK, NIH, 6707 Democracy Boulevard, Bethesda, MD 20892– 5460, 301 451–8048. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: May 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8–10950 Filed 5–16–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4140–01–M National Institutes of Health DEPARTMENT OF HOMELAND SECURITY pwalker on PROD1PC71 with NOTICES National Institute of Diabetes and Digestive and Kidney Disorders; Notice of Closed Meeting [Docket No. DHS–2008–0048] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2) notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The purpose of this meeting is to evaluate requests for preclinical development resources for potential new therapeutics for type I diabetes. The outcome of the evaluation will be a decision whether NIDDK should support the request and make available contract resources for development of the potential therapeutic to improve the treatment or prevent the development of type I diabetes and its complications. The research proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the proposed research projects, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Aug<31>2005 17:18 May 16, 2008 Jkt 214001 Science and Technology Directorate; Submission for Review; Information Collection Request for the DHS S&T Tech Clearinghouse Program Science and Technology Directorate, DHS. ACTION: 60-day Notice and request for comment. AGENCY: SUMMARY: The Department of Homeland Security (DHS) invites the general public to comment on new data collection forms for the Tech Clearinghouse program: Consent Form, Entrance Form, Structured Assessment Case #1, Structured Assessment Case #2, Structured Assessment Case #3, Structured Assessment Case #4, and Exit Form. The Homeland Security Act of 2002 requires the Department of Homeland Security (DHS) Science and Technology Directorate (S&T) to establish a Technology Clearinghouse to encourage and support innovative technical solutions to enhance homeland security and the mission of the Department (Pub. L. 107–296, Section 313). This requirement responds to long-standing requests by the first responder community to create a resource for information and technology PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 28831 that would assist them in support of their mission. In order to assess the current version of the DHS Tech Clearinghouse, a National Online Electronic Assessment (NOEA) will be administered. This notice and request for comments is required by the Paperwork Reduction Act of 1995 (Pub. L. 104–13, 44 U.S.C. chapter 35). DATES: Comments are encouraged and will be accepted until July 18, 2008. Comments: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to Desk Officer for the Department of Homeland Security, Science & Technology Directorate, and sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–6974. Please include docket number [DHS–2008–0048] in the subject line of the message. FOR FURTHER INFORMATION CONTACT: Michael Bowerbank (202) 254–6895 (this is not a toll free number). SUPPLEMENTARY INFORMATION: The Tech Clearinghouse National On-line Assessment (NOEA) will collect information via a secure Web site. The data will be used by DHS S&T to: (1) Assess the overall usability of the Tech Clearinghouse, (2) Assess the specific functions of the Tech Clearinghouse, (3) Assess the relevancy and usefulness of the content of the Tech Clearinghouse to first responders, (4) Assess the ease with which users navigate the Tech Clearinghouse, and (5) Provide general feedback on the Tech Clearinghouse. Information technology will be used in the collection of this information to reduce the data gathering and records management burden. The National Online Electronic Assessment will be conducted with approximately 100 currently employed or recently retired individuals from the first responder disciplines. An invitation to participate in the National Online Electronic Assessment will be distributed through sources such as the First Responder Technologies (R-Tech) User Working Group (UWG), the R-Tech Newsletter, and national and state-level associations representing all first responder disciplines. The sources will announce the opportunity for participation in the NOEA. The assessment will be completely Web-based. DHS S&T will provide a secure Web site, through which individuals can participate in the assessment. DHS has opted to conduct this collection electronically in order to minimize the burden on participants. E:\FR\FM\19MYN1.SGM 19MYN1

Agencies

[Federal Register Volume 73, Number 97 (Monday, May 19, 2008)]
[Notices]
[Page 28831]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10950]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney 
Disorders; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The purpose of this meeting is to evaluate requests 
for preclinical development resources for potential new therapeutics 
for type I diabetes. The outcome of the evaluation will be a decision 
whether NIDDK should support the request and make available contract 
resources for development of the potential therapeutic to improve the 
treatment or prevent the development of type I diabetes and its 
complications. The research proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the proposed research projects, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Type I Diabetes--Rapid Access to Intervention 
Development, Special Emphasis Panel, National Institute of Diabetes 
and Digestive and Kidney Diseases.
    Date: June 3, 2008.
    Time: 12 p.m.-1 p.m.
    Agenda: To evaluate requests for preclinical development 
resources for potential new therapeutics for type I diabetes and its 
complications.
    Place: 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone 
Conference Call).
    Contact Person: Dr. Kristin Abraham, Director, Cell Signaling 
and Diabetes Centers Program, Division of Diabetes, Endocrinology 
and Metabolic Diseases, NIDDK, NIH, 6707 Democracy Boulevard, 
Bethesda, MD 20892-5460, 301 451-8048.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 98.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: May 9, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E8-10950 Filed 5-16-08; 8:45 am]
BILLING CODE 4140-01-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.